This series on “The Treatment of Locally Advanced Lung Cancer” is edited by:
- Davide Tosi, MD, Thoracic Surgery and Lung Transplant Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza, Milan, Italy; and
- Alessandro Palleschi, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
The locally advanced non-small cell lung cancer (NSCLC) has always been a middle ground between surgeon and medical therapy. In the clinical practice, the approach and management of this category of patients represent the moment of greater interaction between different specialties as well an extremely stimulating pathway.
Introduction to the CCTS special series “The treatment of locally advanced lung cancer”
T4 non-small cell lung cancer invading the heart or the major thoracic vessels
Immunotherapy for locally advanced non-small cell lung cancer: current evidence and future perspectives
Multi-modality treatment of locally advanced lung cancer: a focus on radiotherapy
Posterior and anterior sulcus tumors
The outcome of patients treated with salvage surgery after chemo-radiotherapy for locally advanced non-small cell lung carcinoma
Tracheal and carinal resections in the treatment of non-small cell lung cancer: a trend to a minimally invasive approach
Non-small-cell lung cancer involving the pleura: a narrative review on the diagnostic and therapeutic pathway
Surgery after induction chemo or immunotherapy for locally advanced NSCLC
Risk models to predict outcomes following lung cancer surgery: where are we at?
Disclosure:
The series “The Treatment of Locally Advanced Lung Cancer” was commissioned by the editorial office, Current Challenges in Thoracic Surgery without any sponsorship or funding. Davide Tosi and Alessandro Palleschi are serving as the unpaid Guest Editors for the series.